Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07797426 | A Study of RT023 in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 318 | Shanghai Ruotuo Biosciences Co., Ltd.INDUSTRY | 0 | Sep 1, 2026 | clinicaltrials |
| NCT07797660 | A Study for Postoperative Delirium in Older Patients With Intracranial Tumors | not yet recruiting | — | 164 | Beijing Tiantan HospitalOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07797738 | Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma(OPSCC) | not yet recruiting | N/A | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07797907 | This Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer. | not yet recruiting | Phase 1 | 110 | Biolojic Design Ltd.INDUSTRY | 0 | Sep 1, 2026 | clinicaltrials |
| NCT07798362 | Iriscope for the Diagnosis of Peripheral Pulmonary Lesions: a Multicentre Randomised Controlled Trial | not yet recruiting | N/A | 140 | Erasme University HospitalOTHER | 0 | Sep 1, 2026 | clinicaltrials |
| NCT07466498 | Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial | not yet recruiting | Phase 2 | 60 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07484139 | H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)(NEO COMBAT XL) | not yet recruiting | Phase 2 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07664670 | The High Fiber Program to Increase Fiber Intake Among Patients Undergoing Allogeneic Hematopoietic Cell Transplant | not yet recruiting | N/A | 44 | City of Hope Medical CenterOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07736612 | A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer | not yet recruiting | Phase 1 / Phase 2 | 80 | Zhejiang UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07768189 | A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma(TEMPO-1) | not yet recruiting | Phase 3 | 260 | Corbus Pharmaceuticals Inc.INDUSTRY | 3 | Aug 31, 2026 | clinicaltrials |
| NCT07787806 | Patient-reported Outcomes-driven Supportive Care Navigation Among Hispanic/Latinx Cancer Patients | not yet recruiting | N/A | 72 | University of California, IrvineOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07793825 | A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 90 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07793942 | A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002) | not yet recruiting | Phase 2 | 480 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07793994 | Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS Tumors | not yet recruiting | N/A | 130 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07794449 | A Multicenter, Prospective Study on the Diagnostic Efficacy of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence-Assisted Diagnosis for Rapid Diagnosis of Lung Cancer Surgical Specimens | not yet recruiting | — | 335 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07794488 | Platinum-Free Regimen in Nasopharyngeal Carcinoma | not yet recruiting | Phase 2 | 145 | Zhejiang Cancer HospitalOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07794501 | Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma(PREMIO) | not yet recruiting | — | 200 | European Institute of OncologyOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07794969 | Pancreatic Cancer Lifestyle Evolution And Resistance(CLEAR) | not yet recruiting | — | 150 | IRCCS San RaffaeleOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07795099 | A Single-center, Prospective, Exploratory Clinical Study | not yet recruiting | N/A | 30 | LanZhou UniversityOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07795268 | Study to Evaluate the Efficacy and Safety of 177Lu-NYM032 Injection in Participants With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) | not yet recruiting | Phase 3 | 600 | Norroy Bioscience Co., LTDINDUSTRY | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07795294 | Swallowing Rehabilitation Program for Head and Neck Tumor Patients(SREP-HNC) | not yet recruiting | N/A | 80 | Delta University for Science and TechnologyOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07795411 | Prospective Multiomic Analysis in Small-Cell Lung Cancer | not yet recruiting | — | 30 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07795424 | Culmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast Cancer | not yet recruiting | Phase 2 | 33 | Shengjing HospitalOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07795879 | The Genetics Update | not yet recruiting | N/A | 170 | Unity Health TorontoOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07796061 | Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)(LIFT) | not yet recruiting | Phase 1 | 45 | Children's National Research InstituteOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07796100 | A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer | not yet recruiting | Phase 3 | 530 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 0 | Aug 31, 2026 | clinicaltrials |
| NCT07796126 | Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance Status(HNSCC) | not yet recruiting | Phase 2 | 22 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06636721 | Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer(LuCA) | not yet recruiting | N/A | 16 | Duke UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT06926530 | Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations | not yet recruiting | — | 240 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07632235 | A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma | not yet recruiting | Phase 1 / Phase 2 | 112 | Shanghai 6th People's HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07680907 | A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)(LuCaRTE) | not yet recruiting | — | 250 | Janssen-Cilag Farmaceutica Ltda.INDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07765602 | A Study of Rusfertide in Adults With Polycythemia Vera in China | not yet recruiting | Phase 2 | 24 | TakedaINDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07768358 | Tucatinib Continuation Study | not yet recruiting | Phase 4 | 175 | PfizerINDUSTRY | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07780357 | HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B | not yet recruiting | — | 2,000 | Beijing Friendship HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | not yet recruiting | Early Phase 1 | 40 | Lumina Pharmaceuticals IncINDUSTRY | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791446 | End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases. | not yet recruiting | N/A | 65 | Stanford UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791550 | Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy(BDJ-PC) | not yet recruiting | N/A | 96 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791615 | A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma | not yet recruiting | Phase 2 | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Aug 28, 2026 | clinicaltrials |
| NCT07791745 | A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. | not yet recruiting | Phase 2 / Phase 3 | 362 | Taizhou Mabtech Pharmaceutical Co.,LtdINDUSTRY | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791771 | SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes | not yet recruiting | — | 84 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07791979 | High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease | not yet recruiting | N/A | 90 | Zhejiang UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07792109 | Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery(GTSP) | not yet recruiting | N/A | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07792824 | Witness Project Lung | not yet recruiting | N/A | 400 | Hackensack Meridian HealthOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793253 | Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer | not yet recruiting | Phase 2 | 55 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793318 | TR115 in ARID1A-Mutated Advanced Solid Tumors | not yet recruiting | Phase 2 | 50 | Tarapeutics Science Inc.INDUSTRY | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793552 | Needlefree Lidocaine Application for Vulvar Biopsies | not yet recruiting | N/A | 106 | Tufts Medical CenterOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793578 | Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer | not yet recruiting | Phase 1 / Phase 2 | 32 | VA Office of Research and DevelopmentFED | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07793721 | Effects of Risk Presentation Format and Frequently Asked Questions on Breast Cancer Risk Skepticism | not yet recruiting | N/A | 3,000 | University of Colorado, DenverOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT03271632 | Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma | not yet recruiting | Phase 1 / Phase 2 | 20 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05995041 | Universal CAR-T Cells Targeting AML | not yet recruiting | Phase 1 | 30 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 27, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Sep 1, 2026source: clinicaltrials